Transfusion of donor‐type red cells as a single preparative treatment for bone marrow transplants with major ABO incompatibility

BACKGROUND: Major ABO incompatibility of a bone marrow donor and recipient entails the risk of severe hemolytic transfusion reactions.

[1]  I. Slavc,et al.  ABO-incompatible bone marrow transplantation: prevention of hemolysis by alkaline hydration with mannitol diuresis in conjunction with red cell reduced buffy coat bone marrow. , 1992, Wiener klinische Wochenschrift.

[2]  H. Heimpel,et al.  ABO-incompatible bone marrow transplantation. , 1992, Beitrage zur Infusionstherapie = Contributions to infusion therapy.

[3]  T. Spitzer,et al.  Automated processing of human bone marrow can result in a population of mononuclear cells capable of achieving engraftment following transplantation , 1991, Transfusion.

[4]  G. Lucarelli,et al.  Bone marrow transplantation in patients with thalassemia. , 1990, The New England journal of medicine.

[5]  A. Gratwohl,et al.  Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndrome: a survey by the Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG) , 1990, British journal of haematology.

[6]  K. Neftel,et al.  Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation. , 1990, Blood.

[7]  H. Deeg,et al.  Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial. , 1989, Blood.

[8]  A. Gratwohl,et al.  ABO-incompatible bone marrow transplantation: in vivo adsorption, an old forgotten method. , 1987, Transplantation proceedings.

[9]  R. Walker,et al.  Special report: transfusion risks. , 1987, American journal of clinical pathology.

[10]  H. Deeg,et al.  Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  J. Bove.  Transfusion-associated hepatitis and AIDS. What is the risk? , 1987, The New England journal of medicine.

[12]  C. Coffin.  Current issues in transfusion therapy. 1. Risks of infection. , 1986, Postgraduate medicine.

[13]  H. Deeg,et al.  Marrow transplantation for the treatment of chronic myelogenous leukemia. , 1986, Annals of internal medicine.

[14]  Peter D. Issitt,et al.  Applied Blood Group Serology , 1985 .

[15]  C. Buckner,et al.  Whole Blood Immunoadsorption of Anti‐A or Anti‐B Antibodies 1 , 1985, Vox sanguinis.

[16]  H. Prentice,et al.  ABO-INCOMPATIBLE BONE-MARROW TRANSPLANTATION: REMOVAL OF RED BLOOD CELLS FROM DONOR MARROW AVOIDING RECIPIENT ANTIBODY DEPLETION , 1982, The Lancet.

[17]  R. Gale,et al.  ABH Antigens and Bone Marrow Transplantation , 1980, British journal of haematology.

[18]  R. Storb,et al.  ABO‐INCOMPATIBLE MARROW TRANSPLANTS , 1982, Transplantation.

[19]  S. Feig,et al.  ABO blood group system and bone marrow transplantation. , 1977, Blood.

[20]  R Storb,et al.  Technique for human marrow grafting. , 1970, Blood.